Christopher Striebich, MD, PhD

Associate Professor, Medicine-Rheumatology

Faculty Photo
Medical School
  • MD, University of Texas Medical Branch School of Medicine (1991)
Residency
  • University of Colorado, Internal Medicine (1994)
Fellowships
  • University of Colorado, Rheumatology (1997)
Languages
English
Department
Medicine-Rheumatology

Publications

  • Geetha D, Neumann T, Karras A, Cid MC, Merkel PA, Bray S, Bozeman AM, Jayne DRW. Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide. RMD Open. 2025 Oct 5;11(4). PubMed PMID: 41052893
  • He Z, Glass MC, Venkatesan P, Feser ML, Lazaro L, Okada LY, Tran NTT, He YD, Zaim SR, Bennett CE, Ravisankar P, Dornisch EM, Ferrannini AC, Arishi NA, Asamoah AG, Barzideh S, Becker LA, Bemis EA, Buckner JH, Collora CE, Criley MAL, Demoruelle MK, Fleischer CL, Garber J, Genge PC, Gong Q, Graybuck LT, Gustafson CE, Hattel BC, Hernandez V, Heubeck AT, Kawelo EK, Krishnan U, Kuan EL, Kuhn KA, LaFrance CM, Lee KJ, Li R, Lord C, Mettey RR, Moss L, Musgrove B, Nguyen KH, Ochoa A, Parthasarathy V, Pebworth MP, Pedrick C, Peng T, Phalen CG, Reading J, Roll CR, Seifert JA, Siedschlag MD, Speake C, Striebich CC, Stuckey TJ, Swanson EG, Takada H, Thai T, Thomson ZJ, Trieu N, Tsaltskan V, Wang W, Weiss MDA, Westermann A, Zhang F, Boyle DL, Goldrath AW, Bumol TF, Li XJ, Holers VM, Skene PJ, Savage AK, Firestein GS, Deane KD, Torgerson TR, Gillespie MA. Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation. Sci Transl Med. 2025 Sep 24;17(817):eadt7214. PubMed PMID: 40991726
  • Olsen NJ, Liao D, James JA, Guthridge JM, Arriens C, Kamen D, Ishimori M, Wallace DJ, Striebich C, Narain S, Chong BF, He F, Schaefer EW, Chinchilli VM, Karp DR. A Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Incomplete Lupus. Arthritis Rheumatol. 2025 Sep 16. [Epub ahead of print] PubMed PMID: 40955637
  • Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess L, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Demoruelle MK, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis. Arthritis Rheumatol. 2025 Aug 29. [Epub ahead of print] PubMed PMID: 40884017
  • Geetha D, Cortazar FB, Bruchfeld A, Kronbichler A, Karras A, Nakhoul GN, Merkel PA, Bray S, Bozeman AM, Jayne DRW. Treatment With Avacopan in ANCA-Associated Vasculitis With Kidney Involvement. Kidney Int Rep. 2025 Aug;10(8):2751-2765. PubMed PMID: 40814647
  • Geetha D, Pagnoux C, Sattui SE, Merkel PA, Weiner M, Draibe J, Faguer S, Bray S, Gurlin RE, Balcells-Oliver M, Bruchfeld A, Jayne DR. Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial. Rheumatology (Oxford). 2025 Jun 1;64(6):3863-3871. PubMed PMID: 40037556
  • A Phase 2, Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Individuals At-Risk for Future Rheumatoid Arthritis Kevin Deane1, Christopher Striebich2, Marie Feser3, James O'Dell4, Judith James5, Jeffrey Sparks6, John Davis7, Jonathan Graf8, Maureen McMahon9, Elizabeth Solow10, Lindsy Forbess11, Athan Tiliakos12, Elena Schiopu13, David Fox14, Maria I. ("Maio") Danila15, Diane Horowitz16, Jonathan Kay17, Colin Strickland3, Joel Guthridge5, Cristina Arriens5, Jennifer Grossman18, Kristen Demoruelle19, Elizabeth Bemis3, Ashley Frazer-Abel3, Chelsie Fleischer20, Ted Mikuls4, Melissa Greenleaf21, Kate York22, Sarah Walker23, Lynette Keyes-Elstein23, Margie Byron23, Janel Fedler24, Ellen Goldmuntz25 and V. Michael Holers26, 1University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 2University of Colorado, Aurora, CO, 3University of Colorado Anschutz Medical Campus, Aurora, CO, 4University of Nebraska Medical Center, Omaha, NE, 5Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Brigham and Women's Hospital, Boston, MA, 7Mayo Clinic, Rochester, MN, 8UCSF, San Francisco, CA, 9UCLA David Geffen School of Medicine, Los Angeles, CA, 10UT Southwestern Medical Center, Dallas, TX, 11Cedars-Sinai Medical Center, Los Angeles, CA, 12Emory University, Roswell, GA, 13Medical College of Georgia at Augusta University, Martinez, GA, 14University of Michigan, Dexter, MI, 15University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 16Northwell Health, Jericho, NY, 17UMass Chan Medical School, Worcester, MA, 18UCLA, Sherman Oaks, CA, 19University of Colorado Anschutz Medical Campus, Golden, CO, 20University of Colorado Denver, Aurora, CO, 21National Institutes of Health, Rockville, MD, 22Rho, Inc, Durham, NC, 23Rho, Inc., Durham, NC, 24Rho, Inc., Salem, IA, 25NIAID/ NIH, Washington, DC, 26University of Colorado, Denver, CO ACR Convergence 2025
  • Longitudinal peripheral blood multi-omic profiling in at-risk individuals uncovers immune signatures and predictive models for future rheumatoid arthritis conversion Jun Inamo1, Aleksandra Bylinska2, Miles Smith2, Lauren Vanderlinden3, Christian Wright4, Tayte Stephens5, Marie Feser6, Christopher Striebich7, James O'Dell8, Jeffrey Sparks9, John Davis10, Jonathan Graf11, Maureen McMahon12, Elizabeth Solow13, Lindsy Forbess14, Athan Tiliakos15, David Fox16, Maria I. Danila17, Diane Lewis. Horowitz18, Jonathan Kay19, Judith James2, V. Michael Holers20, Kevin Deane21, Joel Guthridge2 and Fan Zhang22, 1University of Colorado School of Medicine, Aurora, CO, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3University of Colorado Anschutz Medical Campus, Monument, CO, 4University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5University of Oklahoma Health Science Center, Oklahoma City, OK, 6University of Colorado Anschutz Medical Campus, Aurora, CO, 7University of Colorado, Aurora, CO, 8University of Nebraska Medical Center, Omaha, NE, 9Brigham and Women's Hospital, Boston, MA, 10Mayo Clinic, Rochester, MN, 11UCSF, San Francisco, CA, 12UCLA David Geffen School of Medicine, Los Angeles, CA, 13UT Southwestern Medical Center, Dallas, TX, 14Cedars-Sinai Medical Center, Los Angeles, CA, 15Emory University, Roswell, GA, 16University of Michigan, Dexter, MI, 17University of Alabama at Birmingham, Birmingham, 18Northwell Health, New Hyde Park, 19UMass Chan Medical School, Worcester, MA, 20University of Colorado Anschutz Medical Campus, Aurora, 21University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 22The University of Colorado, Aurora, CO ACR Convergence 2025
  • He Z, Glass MC, Venkatesan P, Feser ML, Lazaro L, Okada LY, Tran NTT, He YD, Zaim SR, Bennett CE, Ravisankar P, Dornisch EM, Arishi NA, Asamoah AG, Barzideh S, Becker LA, Bemis EA, Buckner JH, Collora CE, Criley MAL, Demoruelle MK, Fleischer CL, Garber J, Genge PC, Gong Q, Graybuck LT, Gustafson CE, Hattel BC, Hernandez V, Heubeck AT, Kawelo EK, Krishnan U, Kuan EL, Kuhn KA, LaFrance CM, Lee KJ, Li R, Lord C, Mettey RR, Moss L, Musgrove B, Nguyen K, Ochoa A, Parthasarathy V, Pebworth MP, Pedrick C, Peng T, Phalen CG, Reading J, Roll CR, Seifert JA, Siedschlag MD, Speake C, Striebich CC, Stuckey TJ, Swanson EG, Takada H, Thai T, Thomson ZJ, Trieu N, Tsaltskan V, Wang W, Weiss MDA, Westermann A, Zhang F, Boyle DL, Goldrath AW, Bumol TF, Li XJ, Holers VM, Skene PJ, Savage AK, Firestein GS, Deane KD, Torgerson TR, Gillespie MA. Systemic inflammation and lymphocyte activation precede rheumatoid arthritis. bioRxiv. 2024 Nov 12. PubMed PMID: 39554042
  • Xia J, Kantipudi S, Striebich CC, Henao-Martinez AF, Manoharan N, Palestine AG, Reddy AK. Cytomegalovirus chronic retinal necrosis with ganciclovir resistance: a case report. J Ophthalmic Inflamm Infect. 2024 Oct 8;14(1):50. PubMed PMID: 39377839
  • Holers VM, Frank RM, Zuscik M, Keeter C, Scheinman RI, Striebich C, Simberg D, Clay MR, Moreland LW, Banda NK. Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament Injury. Immune Netw. 2024 Apr;24(2):e17. PubMed PMID: 38725672
  • Geetha D, Dua A, Yue H, Springer J, Salvarani C, Jayne D, Merkel P. Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial. Ann Rheum Dis. 2024 Jan 11;83(2):223-232. PubMed PMID: 37979959
  • Geetha D, Dua A, Yue H, Springer J, Salvarani C, Jayne D, Merkel P; ADVOCATE Study Group. Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial. Ann Rheum Dis. 2024 Jan 11;83(2):223-232. doi: 10.1136/ard-2023-224816. PMID: 37979959.
  • Holers VM, Frank RM, Clauw A, Seifert J, Zuscik M, Asokan S, Striebich C, Clay MR, Moreland LW, Banda NK. Potential causal role of synovial complement system activation in the development of post-traumatic osteoarthritis after anterior cruciate ligament injury or meniscus tear. Front Immunol. 2023 May 3;14:1146563. doi: 10.3389/fimmu.2023.1146563. PMID: 37207197; PMCID: PMC10189880.
  • Strand V, Jayne DRW, Horomanski A, Yue H, Bekker P, Merkel PA. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial. Lancet Rheumatol. 2023 Aug;5(8):e451-e460. PubMed PMID: 38251577
  • Cortazar FB, Niles JL, Jayne DRW, Merkel PA, Bruchfeld A, Yue H, Schall TJ, Bekker P; ADVOCATE Study Group. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan. Kidney Int Rep. 2023 Feb 3;8(4):860-870. doi: 10.1016/j.ekir.2023.01.039. PMID: 37069984; PMCID: PMC10105055.
  • Conran C, Kolfenbach J, Kuhn K, Striebich C, Moreland L. A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management. Curr Rheumatol Rep. 2023 Dec;25(12):285-294. doi: 10.1007/s11926-023-01117-6. PMID: 37776482.
  • James EA, Holers VM, Iyer R, Prideaux EB, Rao NL, Rims C, Muir VS, Posso SE, Bloom MS, Zia A, Elliott SE, Adamska JZ, Ai R, Brewer RC, Seifert JA, Moss L, Barzideh S, Demoruelle MK, Striebich CC, Okamoto Y, Sainbayar E, Crook AA, Peterson RA, Vanderlinden LA, Wang W, Boyle DL, Robinson WH, Buckner JH, Firestein GS, Deane KD. Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis. Nat Commun. 2023 Nov 22;14(1):7637. doi: 10.1038/s41467-023-43091-8. PMID: 37993439; PMCID: PMC10665556.
  • James EA, Holers VM, Iyer R, Prideaux EB, Rao NL, Rims C, Muir VS, Posso SE, Bloom MS, Zia A, Elliott SE, Adamska JZ, Ai R, Brewer RC, Seifert JA, Moss L, Barzideh S, Demoruelle MK, Striebich CC, Okamoto Y, Sainbayar E, Crook AA, Peterson RA, Vanderlinden LA, Wang W, Boyle DL, Robinson WH, Buckner JH, Firestein GS, Deane KD. Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis. Nat Commun. 2023 Nov 22;14(1):7637. PubMed PMID: 37993439
  • Fleischer CL, Bemis EA, Feser ML, Kormendi VA, Zhang A, Ketcham K, White SD, Striebich CC, Deane KD, Harrison M. Preferences and Insights for Participation in a Rheumatoid Arthritis Clinical Prevention Trial: A Mixed-Methods Study. ACR Open Rheumatol. 2022 Nov;4(11):974-982. PubMed PMID: 36112074
  • Bergstedt DT, Tarter WJ, Peterson RA, Feser ML, Parish MC, Striebich CC, Demoruelle MK, Moss L, Bemis EA, Norris JM, Holers VM, Edison JD, Thiele GM, Mikuls TR, Deane KD. Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis. Front Immunol. 2022;13:916277. PubMed PMID: 35812446
  • Ptacek J, Hawtin RE, Sun D, Louie B, Evensen E, Mittleman BB, Cesano A, Cavet G, Bingham CO 3rd, Cofield SS, Curtis JR, Danila MI, Raman C, Furie RA, Genovese MC, Robinson WH, Levesque MC, Moreland LW, Nigrovic PA, Shadick NA, O'Dell JR, Thiele GM, Clair EWS, Striebich CC, Hale MB, Khalili H, Batliwalla F, Aranow C, Mackay M, Diamond B, Nolan GP, Gregersen PK, Bridges SL Jr. Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity. PLoS One. 2021;16(1):e0244187. PubMed PMID: 33444321
  • Jayne DRW, Merkel PA, Schall TJ, Bekker P. Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med. 2021 Feb 18;384(7):599-609. PubMed PMID: 33596356
  • Ptacek J, Hawtin RE, Sun D, Louie B, Evensen E, Mittleman BB, Cesano A, Cavet G, Bingham CO 3rd, Cofield SS, Curtis JR, Danila MI, Raman C, Furie RA, Genovese MC, Robinson WH, Levesque MC, Moreland LW, Nigrovic PA, Shadick NA, O'Dell JR, Thiele GM, Clair EWS, Striebich CC, Hale MB, Khalili H, Batliwalla F, Aranow C, Mackay M, Diamond B, Nolan GP, Gregersen PK, Bridges SL Jr. Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity. PLoS One. 2021 Jan 14;16(1):e0244187. doi: 10.1371/journal.pone.0244187. PMID: 33444321.
  • Aranow C, Cush J, Bolster MB, Striebich CC, Dall'era M, Mackay M, Olech E, Frech T, Box J, Keating R, Wasko MC, St Clair W, Kivitz A, Huang W, Ricketts P, Welch B, Callahan S, Spychala M, Boyle K, York K, Keyes-Elstein L, Goldmuntz E, Diamond B, Davidson A. A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford). 2020 Jul 1;59(7):1505-1513. PubMed PMID: 31628482
  • Polinski KJ, Bemis EA, Feser M, Seifert J, Demoruelle MK, Striebich CC, Brake S, O'Dell JR, Mikuls TR, Weisman MH, Gregersen PK, Keating RM, Buckner J, Nicassio P, Holers VM, Deane KD, Norris JM. Perceived Stress and Inflammatory Arthritis: A Prospective Investigation in the Studies of the Etiologies of Rheumatoid Arthritis Cohort. Arthritis Care Res (Hoboken). 2020 Dec;72(12):1766-1771. PubMed PMID: 31600025
  • Aranow C, Cush J, Bolster MB, Striebich CC, Dall'era M, Mackay M, Olech E, Frech T, Box J, Keating R, Wasko MC, St Clair W, Kivitz A, Huang W, Ricketts P, Welch B, Callahan S, Spychala M, Boyle K, York K, Keyes-Elstein L, Goldmuntz E, Diamond B, Davidson A. A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford). 2019 Oct 18. [Epub ahead of print] PubMed PMID: 31628482
  • Polinski KJ, Bemis EA, Feser M, Seifert J, Demoruelle MK, Striebich CC, Brake S, O'Dell JR, Mikuls TR, Weisman MH, Gregersen PK, Keating RM, Buckner J, Nicassio P, Holers VM, Deane KD, Norris JM. Perceived stress and inflammatory arthritis: a prospective investigation in the Studies of the Etiologies of Rheumatoid Arthritis (SERA) cohort. Arthritis Care Res (Hoboken). 2019 Oct 10. [Epub ahead of print] PubMed PMID: 31600025
  • West SG, Pearson DW, Striebich CC, Goecker R, Kolfenbach JR. The Effect of Pre-Appointment Consultation Triage on Patient Selection and Revenue Generation in a University Rheumatology Practice. Arthritis Care Res (Hoboken). 2019 May;71(5):689-693. PubMed PMID: 29999252
  • Striebich CC. Drug-Induced Lupus Erythematosus. In: West SG, Kolfenbach J, editors. Rheumatology Secrets 4th ed. Philadelphia: Elsevier; 2019. p. 152-155.
  • Striebich CC. Osteonecrosis. In: West SG, Kolfenbach J, editors. Rheumatology Secrets 4th ed. Philadelphia: Elsevier; 2019. p. 435-440.
  • West SG, Pearson DW, Striebich CC, Goecker R, Kolfenbach JR. The Effect of Pre-appointment Consult Triage on Patient Selection and Revenue Generation in a University Rheumatology Practice. Arthritis Care Res (Hoboken). 2018 Jul 12. [Epub ahead of print] PubMed PMID: 29999252
  • Gan RW, Bemis EA, Demoruelle MK, Striebich CC, Brake S, Feser ML, Moss L, Clare-Salzler M, Holers VM, Deane KD, Norris JM. The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population. Rheumatology (Oxford). 2017 Dec 1;56(12):2229-2236. PubMed PMID: 29029330
  • Deane KD, Striebich CC, Holers VM. Editorial: Prevention of Rheumatoid Arthritis: Now Is the Time, but How to Proceed?. Arthritis Rheumatol. 2017 May;69(5):873-877. PubMed PMID: 28217918
  • West S, Pearson D, Striebich CC, Goecker R, Kolfenbach J. Effect of Pre-Appointment Consult Triage on Patient Selection and Revenue Generation in a University Rheumatology Practice. American College of Rheumatology Annual Meeting; 2017 Nov 4-8; San Diego, CA. Abstract no. 185.
  • Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczynski P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis Rheumatol. 2017 Feb;69(2):362-375. PubMed PMID: 27598855
  • Bemis EA, Ellinwood N, Aiona K, Striebich CC, Deane KD. A Combination of Self-Reported Symptoms and ACPA Testing Can Identify Individuals with Previously Undiagnosed Inflammatory Arthritis in a Health-Fair Setting. American College of Rheumatology Annual Meeting; 2017 Nov 4-8; San Diego, CA. Abstract no. 1055.
  • Wampler Muskardin T, Vashisht P, Dorschner JM, Jensen MA, Chrabot BS, Kern M, Curtis JR, Danila MI, Cofield SS, Shadick N, Nigrovic PA, St Clair EW, Bingham CO 3rd, Furie R, Robinson W, Genovese M, Striebich CC, O'Dell JR, Thiele GM, Moreland LW, Levesque M, Bridges SL Jr, Gregersen PK, Niewold TB. Increased pretreatment serum IFN-ß/a ratio predicts non-response to tumour necrosis factor a inhibition in rheumatoid arthritis. Ann Rheum Dis. 2016 Oct;75(10):1757-62. PubMed PMID: 26546586
  • Ormseth MJ, Yancey PG, Solus JF, Louis Bridges S Jr, Curtis JR, Linton MF, Fazio S, Davies SS, Roberts LJ 2nd, Vickers KC, Kon V, Michael Stein C. Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis. Arthritis Rheumatol. 2016 Sep;68(9):2099-105. PubMed PMID: 26991245
  • Wampler Muskardin T, Vashisht P, Dorschner JM, Jensen MA, Chrabot BS, Kern M, Curtis JR, Danila MI, Cofield SS, Shadick N, Nigrovic PA, St Clair EW, Bingham CO 3rd, Furie R, Robinson W, Genovese M, Striebich CC, O'Dell JR, Thiele GM, Moreland LW, Levesque M, Bridges SL Jr, Gregersen PK, Niewold TB. Increased pretreatment serum IFN-ß/a ratio predicts non-response to tumour necrosis factor a inhibition in rheumatoid arthritis. Ann Rheum Dis. 2015 Nov 6. [Epub ahead of print] PubMed PMID: 26546586
  • Prediction of TNF Inhibitor Response in Rheumatoid Arthritis Patients Using Single Cell Network Profiling of Intracellular Immune Signaling. J. Ptacek, R. Hawtin, B. Louie, E. Evensen, J. Cordeiro, B. Mittleman, M. Atallah, A. Cesano, C. O. Bingham III, S. S. Cofield, J. R. Curtis3, M. I. Danila3, R. Furie4, M. C. Genovese, M. C. Levesque, L. W. Moreland, P. A. Nigrovic, J. R. O'Dell, W. H. Robinson, N. A. Shadick, E. W. St Clair, C. C. Striebich, G. M. Thiele, P. K. Gregersen, S. L. Bridges, Jr.
  • Vashisht P, Dorschner JM, Jensen MA, Chrabot BS, Wampler-Muskardin T, Kern M, TETRAD Investigators, ABCoN consortium, Bridges Jr. SL, Gregersen PK, Niewold TB. Baseline serum interferon beta/alpha ratio predicts response to tumor necrosis factor alpha inhibition in rheumatoid arthritis. Presented at the American College of Rheumatology Annual Meeting; 2014 Nov 14-19; Boston, MA.
  • West SW. Rheumatology Secrets. 3rd ed. Mosby; 2014. Chapter 17, Drug-induced lupus; p. 137-140.
  • Ptacek J, Hawtin RE, Evensen E, Cordeiro J, Atallah M, Marimpietri C, Cesano A, TETRAD Investigators, Gregersen PK, Bridges Jr., SL. Comparison of functional immune signaling profiles in peripheral blood mononuclear cells (PBMC) from rheumatoid arthritis (RA) patients versus healthy donors (HD) using Single Cell Network Profiling (SCNP).
  • Liubchenko GA, Appleberry HC, Striebich CC, Franklin KE, Derber LA, Holers VM, Lyubchenko T. Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes. J Autoimmun. 2013 Feb;40:111-21. PubMed PMID: 23058039
  • Health Fair Evaluations To Identify Subjects At-Risk For Future Inflammatory Arthritis and Rheumatoid Arthritis. Beck, Kristen E. MA MS2; Demoruelle, M. Kristen MD; Striebich, Christopher C. MD, PhD; Aiona, Kaylynn MPH; Feser, Marie L. MSPH; Derber, Lezlie A. MSPH; Brake, Stacey RN BSN; Lysengen, Jill ; Rosseisen, Laura ; Rhiannon, Julia J. MD; Weisman, Stuart M. MD; Norris, Jill M. MPH, PhD; Holers, V. Michael MD; Deane, Kevin D. MD, PhD
  • Prediction Of TNF Inhibitor Response In Rheumatoid Arthritis Patients Using Single Cell Network Profiling Of Intracellular Immune Signaling. Ptacek, Jason PhD; Hawtin, Rachael PhD; Louie, Brent PhD; Evensen, Erik PhD; Cordeiro, James ; Mittleman, Barbara MD; Atallah, Michelle BS; Cesano, Alessandra MD, PhD; Bingham, Clifton O. MD; Cofield, Stacey PhD; Curtis, Jeffrey R. MD, MPH, MS; Danila, Maria I. MD, MSc; Furie, Richard A. MD; Genovese, Mark C. MD; Levesque, Marc C. MD, PhD; Moreland, Larry W. MD; Nigrovic, Peter A. MD; O'Dell, James R. MD; Robinson, William H. MD, PhD; Shadick, Nancy A. MD, MPH; St Clair, E. William M.D.; Striebich, Christopher C. MD, PhD; Thiele, Geoffrey M Ph.D.; Gregersen, Peter K. MD; Bridges, S. Louis MD, PhD
  • Assessment Of The Diagnostic Accuracy Of Different Strategies For Health Fair Case-Finding For Undiagnosed Inflammatory Arthritis. Aiona, Kaylynn MPH; Striebich, Christopher C. MD, PhD; Demoruelle, M. Kristen MD; Rhiannon, Julia J. MD; Weisman, Stuart M. MD; Feser, Marie L. MSPH; Derber, Lezlie A. MSPH; Goddard, James H. BS MHA; Brake, Stacey RN BSN; Lysengen, Jill ; Rosseisen, Laura ; Hokanson, John E. MPH PhD; Baron, Anna E. PhD; Norris, Jill M. MPH, PhD; Holers, V. Michael MD; Deane, Kevin D. MD, PhD
  • Novel Biomarkers From Peripheral Blood Mononuclear Cells Indicate Disease Activity In Rheumatoid Arthritis Patients. Ptacek, Jason PhD; Hawtin, Rachael PhD; Louie, Brent PhD; Evensen, Erik PhD; Cordeiro, James ; Mittleman, Barbara MD; Atallah, Michelle BS; Cesano, Alessandra MD, PhD; Bingham, Clifton O. MD; Cofield, Stacey PhD; Curtis, Jeffrey R. MD, MPH, MS; Danila, Maria I. MD, MSc; Furie, Richard A. MD; Genovese, Mark C. MD; Levesque, Marc C. MD, PhD; Moreland, Larry W. MD; Nigrovic, Peter A. MD; O'Dell, James R. MD; Robinson, William H. MD, PhD; Shadick, Nancy A. MD, MPH; St Clair, E. William M.D.; Striebich, Christopher C. MD, PhD; Thiele, Geoffrey M Ph.D.; Gregersen, Peter K. MD; Bridges, S. Louis MD, PhD
  • A Double-Blind Randomized Placebo-Controlled Trial Of Lovastatin in Patients with Rheumatoid Arthritis. Aranow, Cynthia MD, Cush, John J. MD; Bolster, Marcy B. MD; Striebich, Christopher C. MD, PhD; Dall'Era, Maria MD; Mackay, Meggan MD, MS; Olech, Ewa MD; Frech, Tracy M. MD; Box, J. MD; Keating, Richard M. MD; Wasko, Mary Chester M. MD, MSc; St Clair, E. William M.D.; Kivitz, Alan MD; Diamond, Betty MD; Davidson, Anne MBBS; Spychala, Meagan DrPH; Goldmuntz, Ellen A. MD, PhD
  • Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes. Liubchenko GA, Appleberry HC, Striebich CC, Franklin KE, Derber LA, Holers VM, Lyubchenko T. J Autoimmun. 2013 Feb;40:111-21. PMID:23058039
  • Pedler M, Striebich CC, Eisenmesser EZ, Moldawer LM, Fujita M, Norris DA, Edwards CM. Identification of soluble Immunophilin FKBP52 as a potent macrophage activation factor. J Invest Dermatol. 2012. 132, S106.
  • Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, Harrington AR, Kolfenbach JR, Striebich CC, Pham QN, Strickland CD, Petersen BD, Parish MC, Derber LA, Norris JM, Holers VM, Deane KD. Arthritis Rheum. 2012 Jun;64(6):1756-61. doi: 10.1002/art.34344. Epub 2011 Dec 19. PMID:22183986
  • Susac Syndrome and Pregnancy: Disease Management. Deane KD, Tyler KN, Johnson DW, Tanabe JL, Oskarrson BE, Nitka EE, Brass E, Davies JK, Striebich CC. J Clin Rheumatol. 2011 Feb 10. PMID:21325959
  • Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: Early injury or initiating site of autoimmunity? Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, Harrington AR, Kolfenbach JR, Striebich CC, Pham QN, Strickland CD, Petersen BD, Parish MC, Derber LA, Norris JM, Holers VM, Deane KD. Arthritis Rheum. 2011 Dec 19. [Epub ahead of print] PMID:22183986
  • Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis. Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Laura Lisk L, Solomons N for the ALMS Group. N Engl J Med. 2011 Nov 17;365(20):1886-95. PMID:22087680
  • Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial. Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA; ALMS Group. Arthritis Rheum. 2010 Jan;62(1):211-21. Erratum in: Arthritis Rheum. 2010 Oct;62(10):3005. PMID:20039429
  • Deane KD, Striebich CC, Goldstein BL, Derber LA, Parish MC, Feser M, Hamburger EM, Brake S, Belz C, Goddard J, Norris JM, Karlson EW, Holers VM. Identification of Undiagnosed Inflammatory Arthritis and Rheumatoid Arthritis in a 3 Community Health-Fair Screen. Arth Rheum, Submitted.
  • Deane, K., C.C. Striebich, B. Goldstein, L. Derber, M. Parish, M. Feser, E. Hamburger, S. Brake, C. Belz, J. Goddard, J. Norris, E.W. Karlson, V.M. Holers. Identification of Undiagnosed Inflammatory Arthritis in a Community Health-Fair Screen. Arthritis Res Ther. 2009;61:1642-1649.
  • Variability in the biological response to anti-CD20 B-cell depletion in SLE Daniel Albert, MD, Jonathan Dunham, MD, Sadia Khan, MD, Janet Stansberry, RN, Sharon Kolasinski, MD, Donald Tsai, MD, PhD, Sally Pullman-Mooar, MD, Felicia Barnack, BA, Christopher Striebich, MD, PhD, R John Looney, MD, Eline T. Luning Prak, MD, PhD, Robert Kimberly, MD, Yawei Zhang, PhD, Robert Eisenberg, MD Ann Rheum Dis published online 4 Feb 2008;
  • Identification of Transcript Biomarkers in Active Lupus Using Stabilized Whole Blood
  • Systemic Lupus Erythematosus, in Rheumatology Secrets, 3rd ed., Sterling West ed., Elsevier, Philadelphia.
  • Drug Induced Lupus, in Rheumatology Secrets, 3rd ed., Sterling West ed., Elsevier, Philadelphia.
View All (63 Total) View Less

Practice Locations

UCHealth Rheumatology Clinic - Anschutz Medical Campus
1635 Aurora Ct
4th Floor
Aurora, CO 80045
720-848-7700

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Rheumatology, Board Certification (2001)
  • Internal Medicine, Board Certification
Clinical Interests
I am interested in treating Rheumatoid Arthritis, Systemic Lupus Erythematosus and in Clinical Trials in Rheumatic Diseases.

School of Medicine

CU Anschutz

Fitzsimons Building

13001 East 17th Place

Campus Box C290

Aurora, CO 80045

303.724.5375

School
General
Students